Search research articles
Contact Us
Filters
Showing results (11-20 of 327) with videos related to
Page
of 33
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 30, 2002
C-reactive protein and cardiovascular disease: a review of risk prediction and interventions
Sarah de Ferranti, Nader Rifai
Current Opinion in Lipidology
|
August 2, 2002
Inflammatory markers and coronary heart disease
Nader Rifai, Paul M Ridker
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
June 3, 2010
What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema
Adam S Ptolemy, Nader Rifai
Clinical Chemistry
|
March 26, 2003
Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation
Nader Rifai, Paul M Ridker
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 6, 2004
Quality specifications and the assessment of the biochemical risk of atherosclerosis
Nader Rifai, G Russell Warnick
Clinical Chemistry
|
July 26, 2003
Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment
Thomas B Ledue, Nader Rifai
Clinical Chemistry
|
August 31, 2006
Biomarker discovery and validation
Nader Rifai, Robert E Gerszten
Circulation
|
January 16, 2013
Expanding options for scientific publication: is more always better?
Paul M Ridker, Nader Rifai
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
January 16, 2007
C-reactive protein: a nontraditional serum marker of cardiovascular risk
Sarah D de Ferranti, Nader Rifai
Clinical Chemistry
|
July 31, 2012
Colloquium on rethinking the future of scientific communication
Nader Rifai, Michael Keller, John Sack
Page
of 33
Search research articles
Search
Showing results (11-20 of 327) with videos related to
Sort By:
Page
of 33
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 30, 2002
C-reactive protein and cardiovascular disease: a review of risk prediction and interventions
Sarah de Ferranti, Nader Rifai
Current Opinion in Lipidology
|
August 2, 2002
Inflammatory markers and coronary heart disease
Nader Rifai, Paul M Ridker
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
June 3, 2010
What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema
Adam S Ptolemy, Nader Rifai
Clinical Chemistry
|
March 26, 2003
Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation
Nader Rifai, Paul M Ridker
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 6, 2004
Quality specifications and the assessment of the biochemical risk of atherosclerosis
Nader Rifai, G Russell Warnick
Clinical Chemistry
|
July 26, 2003
Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment
Thomas B Ledue, Nader Rifai
Clinical Chemistry
|
August 31, 2006
Biomarker discovery and validation
Nader Rifai, Robert E Gerszten
Circulation
|
January 16, 2013
Expanding options for scientific publication: is more always better?
Paul M Ridker, Nader Rifai
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
January 16, 2007
C-reactive protein: a nontraditional serum marker of cardiovascular risk
Sarah D de Ferranti, Nader Rifai
Clinical Chemistry
|
July 31, 2012
Colloquium on rethinking the future of scientific communication
Nader Rifai, Michael Keller, John Sack
Page
of 33